Catheter-based thrombectomy for clot-in-transit and massive pulmonary embolism in a young patient with rheumatoid arthritis: inflammation as a hidden catalyst for catastrophic thromboembolism
European Journal of Case Reports in Internal Medicine · 18.08.2025 · 12 (9)
DOI: 10.12890/2025_005695 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Case Reports in Internal Medicine, online erschienen am 18.08.2025. Verfasst von Han Shin Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, University of California, Riverside School of Medicine, Riverside, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Pulmonary embolism (PE) is a life-threatening condition with well-defined management strategies; however, the presence of a clot-in-transit (CIT)—a mobile thrombus within the right heart—introduces a uniquely high-risk scenario associated with a significantly elevated mortality rate. While several therapeutic approaches are available—including anticoagulation, systemic thrombolysis, surgical embolectomy, and catheter-directed therapies—there is no established consensus on a superior treatment modality. Catheter-based mechanical thrombectomy has emerged as a promising, minimally invasive alternative that mitigates the bleeding risks of systemic thrombolysis and the invasiveness of surgery. Case description: A 37-year-old male with untreated rheumatoid arthritis presented to the emergency department with dyspnea and chest pain, ultimately found to have massive bilateral PE with CIT. This was successfully treated with percutaneous thrombectomy using the INARI FlowTriever device (Inari Medical, USA).
Discussion
This case is accompanied by uncommon post-thrombectomy imaging that vividly demonstrates the thrombus burden in the majority of bilateral pulmonary vessels, providing valuable visual insight into the disease process and intervention efficacy. Rheumatoid arthritis is an independent risk factor for PE, deep vein thrombosis, and venous thromboembolism, highlighting the importance of treatment.
Conclusion
This report contributes to the limited literature on atypical CIT presentations, highlights the need for standardized treatment algorithms, and demonstrates the success of catheter-directed mechanical thrombectomy in these scenarios.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, University of California, Riverside School of Medicine, Riverside, USA.
- Internal Medicine, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, USA.
Zitieren
APA
Shin Lee, H., Ordookhanian, C., Amidon, R., & Tabibian, B. (2025). Catheter-based thrombectomy for clot-in-transit and massive pulmonary embolism in a young patient with rheumatoid arthritis: inflammation as a hidden catalyst for catastrophic thromboembolism. European Journal of Case Reports in Internal Medicine, 12(9). https://doi.org/10.12890/2025_005695
Vancouver
Shin Lee H, Ordookhanian C, Amidon R, Tabibian B. Catheter-based thrombectomy for clot-in-transit and massive pulmonary embolism in a young patient with rheumatoid arthritis: inflammation as a hidden catalyst for catastrophic thromboembolism. European Journal of Case Reports in Internal Medicine. 2025;12(9). doi:10.12890/2025_005695
BibTeX
@article{ShinLee2025,
author = {Shin Lee, Han and Ordookhanian, Christ and Amidon, Ryan and Tabibian, Benjamin},
title = {Catheter-based thrombectomy for clot-in-transit and massive pulmonary embolism in a young patient with rheumatoid arthritis: inflammation as a hidden catalyst for catastrophic thromboembolism},
journal = {European Journal of Case Reports in Internal Medicine},
year = {2025},
volume = {12},
number = {9},
doi = {10.12890/2025_005695}
}
EUVIMED